What You Should Know:
– Anthem Blue Cross and Blue Shield in Virginia and Aledade, the nation’s largest network of independent primary care, today announced an expansion of their collaboration to provide more Virginians with access to high-quality primary care.
– The expanded strategic partnership will impact more than 80 practices, 15 health centers, and 25 rural health clinics across Virginia and covers Medicare Advantage, commercially insured, or Medicaid members.
– Aledade is particularly focused on bringing the benefits of value-based care to underserved communities and those receiving care through community health centers (CHCs). The company currently serves as a partner to 15 of Virginia’s 26 CHCs and supports the care of more than 90% of Anthem’s CHC members in Virginia.
Improved Outcomes for Diabetes and Breast Cancer Screening
Anthem and Aledade’s collaboration has already demonstrated positive results. In 2022, primary care practices and CHCs working with the two organizations improved their rates of hemoglobin A1c testing by 10% for patients with diabetes, reaching 9 out of every 10 eligible patients. They also achieved high levels of kidney health evaluation for patients with diabetes. Additionally, practices working with Anthem and Aledade ensured that 3 out of every 4 patients eligible for breast cancer screening received a mammogram.
Shared Savings and Reinvestment in Care Delivery
Shared savings generated through value-based care provide valuable revenue that can be reinvested in care delivery. In Virginia, this high-quality care led to substantial savings among Anthem’s commercially-insured patients, bringing more than $2M in shared savings payments back into community primary care.
“Putting our members and consumers at the center of what we do is our priority through partnerships with innovative companies like Aledade,” said Mark Schneider, Regional Vice President Medicare Market Performance. “Together, we can address the health of people and our healthcare system in the right way, improving health outcomes and lowering costs.”
